{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:11:50Z","timestamp":1709889110539},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<p><strong>ABSTRACT<\/strong><br \/><strong>BACKGROUND.<\/strong> HCV infection continues to be a significant public health problem in Europe. The aim of the\u00a0study was to assess the epidemiological situation of hepatitis C in Poland in 2019, based on data collected as part\u00a0of epidemiological surveillance in 2019, comparing them to data from previous years.<br \/><strong>MATERIAL AND METHODS.<\/strong> The following were analyzed: 1) data from epidemiological surveillance in\u00a02019 2) diagnosis rates from \u201cInfectious Diseases and Poisonings in Poland\u201d bulletins for the years 2013-2019\u00a03) data on deaths due to hepatitis C from the Demographic Surveys and Labour Market Department of the\u00a0Statistics Poland.<br \/><strong>RESULTS.<\/strong> In 2019, the HCV diagnosis rate was 8.71 per 100 thousand \u2013 a total of 3 343 cases of HCV infection\u00a0were reported. This was a slight decrease compared to 2018. Still we observe the rate differentiation, territorial\u00a0(differences in the value of the diagnosis rate are noticeable already at the voivodeship and poviat level) and\u00a0demographic (higher rates in men than in women, higher rates in urban than in rural areas), which is probably\u00a0related to HCV testing accessibility. Among acute hepatitis C cases according to the EU definition, indicative\u00a0of current HCV transmission, exposures related to health care (haemodialysis and nosocomial transmission)\u00a0were identified, followed by non-medical injection (community needle stick injuries, tattoos, piercings) and\u00a0sexual contact. A low number of diagnoses (5.9%; 196\/3343) among people who inject drugs indicate diagnostic\u00a0difficulties.<br \/><strong>CONCLUSIONS.<\/strong> For years, the overview of hepatitis C in Poland, observed in epidemiological surveillance,\u00a0has been determined by the availability of HCV testing. Developing the comfortable testing + treatment system\u00a0in Poland that reaches people exposed to the current transmission of HCV infection (bearing in mind the\u00a0possibility of re-infection) is the only possibility of eradication of HCV infections<\/p>\n<p><strong>STRESZCZENIE<\/strong><br \/><strong>WPROWADZENIE.<\/strong> Zaka\u017cenia wirusem HCV stanowi\u0105 nadal istotny problem zdrowia publicznego w Europie.<br \/>Celem pracy by\u0142a ocena sytuacji epidemiologicznej wzw C w Polsce w 2019 r., na podstawie danych\u00a0zebranych w ramach nadzoru epidemiologicznego w 2019 r., por\u00f3wnuj\u0105c je do danych z lat ubieg\u0142ych<br \/><strong>MATERIA\u0141 I METODA.<\/strong> Przeanalizowano: 1) dane z nadzoru epidemiologicznego w 2019 2) wska\u017aniki rozpozna\u0144\u00a0z biuletyn\u00f3w \u201eChoroby zaka\u017ane i zatrucia w Polsce\u201d za lata 2013-2019 oraz 3) dane dotycz\u0105ce zgon\u00f3w\u00a0z powodu wzw C z Departamentu Bada\u0144 Demograficznych i Rynku Pracy G\u0142\u00f3wnego Urz\u0119du Statystycznego.<br \/><strong>WYNIKI.<\/strong> W 2019 r wsp\u00f3\u0142czynnik rozpozna\u0144 zaka\u017ce\u0144 HCV wyni\u00f3s\u0142 8,71 na 100 tys. \u2013 \u0142\u0105cznie zg\u0142oszono\u00a03 343 przypadki zaka\u017cenia HCV. Odnotowano niewielki spadek w por\u00f3wnaniu do 2018 r. Wci\u0105\u017c odnotowujemy\u00a0zr\u00f3\u017cnicowanie wska\u017anik\u00f3w, terytorialne (r\u00f3\u017cnice mi\u0119dzy wojew\u00f3dztwami, powiatami) oraz demograficzne\u00a0(wi\u0119ksze wska\u017aniki u m\u0119\u017cczyzn ni\u017c kobiet, wi\u0119ksze wska\u017aniki w miastach ni\u017c na wsi), co wi\u0105\u017ce si\u0119 zapewne\u00a0z dost\u0119pem do test\u00f3w w kierunku zaka\u017cenia HCV. W\u015br\u00f3d przypadk\u00f3w ostrych wzw C wg. definicji UE, \u015bwiadcz\u0105cych o bie\u017c\u0105cej transmisji HCV, zidentyfikowano nara\u017cenia zwi\u0105zane z kontaktem z opiek\u0105 zdrowotn\u0105 \u2013 hemodializy\u00a0oraz zaka\u017cenia zwi\u0105zane z pobytem w plac\u00f3wce ochrony zdrowia, nast\u0119pnie zabiegi pozamedyczne\u00a0i kontakty seksualne. Niewielka liczba rozpozna\u0144 (5,9%; 196\/3343) w grupie os\u00f3b przyjmuj\u0105cych substancje\u00a0psychoaktywne w iniekcji wskazuje na trudno\u015bci diagnostyczne.<br \/><strong>WNIOSKI.<\/strong> Od lat obraz wzw C w Polsce, obserwowany w nadzorze epidemiologicznym, jest determinowany\u00a0dost\u0119pno\u015bci\u0105 do testowania w kierunku zaka\u017ce\u0144 HCV. Stworzenie w Polsce komfortowego systemu\u00a0testowanie+leczenie docieraj\u0105cego do os\u00f3b nara\u017conych na bie\u017c\u0105c\u0105 transmisj\u0119 zaka\u017cenia HCV (pami\u0119taj\u0105c\u00a0o mo\u017cliwo\u015bci re-infekcji) jest jedyn\u0105 mo\u017cliwo\u015bci\u0105 eradykacji zaka\u017ce\u0144 HCV.<\/p><\/jats:p>","DOI":"10.32394\/pe.75.35","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T09:36:02Z","timestamp":1645090562000},"page":"379-389","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C in Poland in 2019"],"prefix":"10.32394","volume":"75","author":[{"given":"K","family":"Zakrzewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rosi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2022,2,15]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["Wirusowe zapalenie w\u0105troby typu C w Polsce w 2019 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181018-101578","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181018-101578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:44:50Z","timestamp":1709887490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Hepatitis-C-in-Poland-in-2019,181018,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["181018"],"URL":"https:\/\/doi.org\/10.32394\/pe.75.35","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}